Cigna Raises FY23 Sales Guidance To $190B, From Prior Guidance Of $188B Vs. Consensus Of $191.69B; Reaffirms 2023 Adjusted EPS Outlook Of At Least $24.70, Vs. Consensus Of $24.69
Portfolio Pulse from Benzinga Newsdesk
Cigna has increased its FY23 sales guidance to $190B, up from the previous guidance of $188B, but slightly below the consensus of $191.69B. The company has also reaffirmed its 2023 adjusted EPS outlook of at least $24.70, in line with the consensus of $24.69.
August 04, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cigna's raised FY23 sales guidance and reaffirmed EPS outlook may have a positive impact on its stock in the short term.
Cigna's raised sales guidance for FY23 and reaffirmed EPS outlook for 2023 indicates strong financial performance, which is likely to be viewed positively by investors and could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100